Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency VirusFrédérique Chammartin, Robert Zangerle, Colette Smith et al.|Clinical Infectious Diseases|2023Cited by 27
The personalized approach to rituximab treatment in membranous nephropathy: a multi-center randomized controlled trialVesna Brglez, Barbara Seitz‐Polski, Maxime Teisseyre et al.|EClinicalMedicine|2025Cited by 4